Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 12.2K | 49.2K | 48.9K | 47.9K |
Selling general and admin | 107.1K | 51.3K | 159.4K | 51.7K |
Other operating expenses | — | — | — | — |
Operating income | -119.3K | -100.6K | -208.2K | -99.6K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 3.5K | 4 | -661 | -22.8K |
Pretax income | -115.8K | -100.6K | -209.0K | -122.7K |
Tax provision | — | — | — | — |
Net income | -115.8K | -100.6K | -209.0K | -122.7K |
Basic EPS | 0.0 | 0.0 | — | 0.0 |
Diluted EPS | 0.0 | 0.0 | — | 0.0 |
Basic average shares | 88.7M | 88.7M | — | 88.7M |
Diluted average shares | 88.7M | 88.7M | — | 88.7M |
EBITDA | -121.6K | -100.6K | -211.4K | -97.9K |
Net income from continuing op. | -115.8K | -100.6K | -209.0K | -122.7K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |